MONDAY, Dec. 20 (HealthDay News) — People with psoriasis are at increased risk for a cluster of cardiovascular risk factors known as metabolic syndrome, a new study has found.
The features that make up metabolic syndrome include obesity, high blood pressure, diabetes and high total cholesterol and triglyceride levels, according to background information in the study. Psoriasis is a common skin problem caused by a problem with the immune system.
By Amanda Gardner
HealthDay Reporter
TUESDAY, Aug. 17 (HealthDay News) — Women who drink regular beer may be increasing their risk of developing psoriasis, an autoimmune disorder affecting the skin, new findings suggest.
Other options, such as light beer and wine, were not linked to such a risk.
MONDAY, May 17 (HealthDay News) — Patients who take drugs like Accutane and Soriatane for acne and psoriasis don’t seem to be at higher risk of breaking bones, a new study finds, even though similar dietary supplements have been linked to fractures.
Accutane and Soriatane — known generically as isotretinoin and acitretin — are similar to vitamin A, which has been linked to broken bones when taken in high doses. The drugs themselves, which are used to treat acne and psoriasis, have been connected to lower levels of bone density.
FRIDAY, April 23 (HealthDay News) — The low point for country music star LeAnn Rimes came when her psoriasis got so bad she actually started bleeding onstage.
“I would bleed onstage because my skin would crack. It was so horrible,” she said.
“Psoriasis definitely takes a physical and emotional toll. I’ve had to deal with people judging me,” she added.
That is why Rimes is teaming up with the American Academy of Dermatology and the National Psoriasis Foundation to be a spokeswoman for the Stop Hiding From Psoriasis awareness campaign. Read More
WEDNESDAY, April 21 (HealthDay News) — Scientists have discovered several genes linked to vitiligo that confirm the skin condition is, indeed, an autoimmune disorder.
Vitiligo is a pigmentation disorder that causes white splotches to appear on the skin; the late pop star Michael Jackson suffered from the condition. The finding could lead to treatments for this confounding condition, the University of Colorado researchers said. Read More
SATURDAY, March 13 (HealthDay News) — The common skin ailment psoriasis may boost the risk for heart attack, stroke and other cardiovascular woes, probably through a shared inflammatory response, a new Danish study found.
“There is mounting evidence for psoriasis as a risk factor for cardiovascular disease,” study lead researcher Dr. Ole Ahlehoff, from Copenhagen University Hospital Gentofte, said during a Saturday morning press conference at the annual meeting of the American College of Cardiology, in Atlanta. “We are nearing in on a point where we need to reconsider how to mange patients with psoriasis. We need to consider the question of if psoriasis patients are due for statin therapy earlier than predicted by traditional risk scores.” Read More
MONDAY, Jan. 18 (HealthDay News) — The cost of treating psoriasis is rising faster than inflation, says a U.S. study, which also found that newer, biologically-derived treatments cost more than traditional systemic therapies.
The researchers created a cost model to analyze the total cost of systemic therapy for psoriasis, a chronic autoimmune skin disease that affects 4.5 million to 7.5 million Americans and costs the nation’s health-care industry more than $3 billion a year. Read More
WEDNESDAY, Jan. 13 (HealthDay News) — The estimated 7.5 million Americans suffering from psoriasis often have to tolerate long-term treatment that may be only moderately effective.
Now, a new drug called ustekinumab (Stelara) appears to be more effective than the old standby, etanercept (Enbrel), according to the results of a head-to-head comparison sponsored by the maker of Stelara.
“Ustekinumab is a more effective and faster acting therapy for psoriasis than the current biologic market leader for this condition,” said lead researcher Dr. Christopher E.M. Griffiths, a professor of dermatology at the University of Manchester in England. Read More
WEDNESDAY, Dec. 30 (HealthDay News) — Researchers have long wondered why placebos — fake medications — sometimes help sick patients get better.
Now, a new study says placebos can help psoriasis patients get by on smaller doses of a steroid drug that dampens their immune systems.
The study authors, from the University of Rochester Medical Center in New York, think they may be able to develop other treatments that rely on the placebo effect to boost the power of lower doses of existing drugs. Read More
FRIDAY, Sept. 25 (HealthDay News) — Stelara (ustekinumab) has been approved by the U.S. Food and Drug Administration for adults with moderate-to-severe plaque psoriasis.
The immune system disorder is characterized by the rapid overproduction of skin cells, which leads to red, scaly patches of inflamed skin. Some six million people in the United States have plaque psoriasis, the FDA said in a news release. Read More
| Text Size: |  |
|
